Literature DB >> 8448636

The immunopathogenesis of rheumatoid arthritis.

G S Panayi1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8448636

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  10 in total

Review 1.  B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.

Authors:  T Shaw; J Quan; M C Totoritis
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells.

Authors:  C Iking-Konert; B Ostendorf; O Sander; M Jost; C Wagner; L Joosten; M Schneider; G M Hänsch
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

3.  The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis.

Authors:  D M Chang; S F Chiao
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 4.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 5.  Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.

Authors:  Alexandros A Drosos
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Rheumatoid arthritis, periodontal disease and coronary artery disease.

Authors:  S Abou-Raya; A Abou-Raya; A Naim; H Abuelkheir
Journal:  Clin Rheumatol       Date:  2007-08-29       Impact factor: 2.980

7.  A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.

Authors:  D Elewaut; F De Keyser; N De Wever; D Baeten; N Van Damme; G Verbruggen; C Cuvelier; E M Veys
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

8.  Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls.

Authors:  N J Goodstone; M C Doran; R N Hobbs; R C Butler; J J Dixey; B A Ashton
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

Review 9.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

10.  Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.

Authors:  P H Hart; M J Ahern; M D Smith; J J Finlay-Jones
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.